Twelve-Five to achieve sales revenue of 60 billion yuan

February 23, Canton Pharmaceutical Group held the "Twelve-Five" development strategy and planning implementation Mobilization Conference.　　Canton Pharmaceutical Group general manager Li Chuyuan said that by 2015, Canton Pharmaceutical group will achieve sales revenue of more than 60 billion yuan. At present, Canton Pharmaceutical Group has 21 kinds of chemical agents, proprietary Chinese medicine dosage forms 16 kinds of total 1983 varieties of specifications.　　The group has a gap in the country's base of 20, has a number of research and development centers and post-doctoral workstations, with South China's largest pharmaceutical retail network and logistics distribution center. In sales revenue, 2010 Canton Pharmaceutical Group Annual sales revenue of 27.5 billion yuan, of which industrial sales 9.2 billion yuan, commercial sales of 18.3 billion yuan.　　The group will be based on the existing business composition, the target of 60 billion of revenue will be broken down: "Twelve-Five" period, the pharmaceutical industry will strive for the annual average growth of not less than 18.29%, to achieve the industrial scale of 20 billion yuan target; Product structure, Canton Pharmaceutical Group will focus on the construction of 100 million to 2 billion yuan at all levels of the breakdown of the variety of projects.　　The formation of Super billion product series group, covering diabetes, cardiovascular, anti-bacterial anti-inflammatory, biological vaccines and other key areas.　　Logistics industry, will be based on the integration of the internal resources of Canton Pharmaceutical Group, to achieve centralized and unified procurement, reduce costs, speed up the National logistics network of Canton Pharmaceutical group construction.　　In the large health industry, the 35-year Canton Pharmaceutical group will be the king of Old Kat brand as the core, in medicine, health products, cosmetics, family medical equipment, beauty, leisure and fitness and other areas of diversified development, the formation of plant beverages, food and health wine, pharmaceutical products, such as Products series. At the same time, Li Chuyuan revealed that Canton Pharmaceutical Group will take capital as a link to promote investment mergers and acquisitions. In the need of more than 1 billion yuan to invest in the Canton Pharmaceutical Industrial Park Construction, will be the group financing, in the industrial expansion, the horizontal and vertical mergers and acquisitions, expansion of business areas and industrial scale.